Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Aclaris Therapeutics, Inc. (ACRS)
USD5.54
+0.11 (+2.03%)
US NASDAQ Healthcare Biotechnology
Address
640 Lee Road 19087
Wayne, PA, US
Wayne, PA, US
CEO
Neal S. Walker
Website
aclaristx.com
IPO
2015-10-06
CIK 1557746 ISIN US00461U1051
Also trades on
London Stock Exchange · 0H8T.L (USD)
NASDAQ Global Select · ACRS (USD)
Description
Aclaris Therapeutics, Inc., a biopharmaceutical firm operating in the United States, is currently in the clinical development phase, focused on creating novel therapeutic agents for various immune-inflammatory conditions. The company's operations are divided into two primary divisions: the Therapeutics segment, dedicated to discovering and progressing innovative treatments to address crucial unmet needs in immuno-inflammatory disorders; and the Contract Research segment, which delivers specialized laboratory services. The company's pipeline features several investigational compounds. Among these is Zunsemetinib, an MK2 inhibitor, being developed to treat moderate to severe cases of rheumatoid arthritis, psoriatic arthritis, and hidradenitis suppurativa. Another significant candidate is ATI-1777, a soft JAK 1/3 inhibitor, intended for the management of moderate to severe atopic dermatitis. Additionally, Aclaris is advancing ATI-2138, an ITK/TXK/JAK3 inhibitor, as a potential intervention for T cell-mediated autoimmune diseases; a Gut-Biased Program targeting inflammatory bowel disease; and ATI-2231, an MK2 inhibitor, for the treatment of pancreatic and metastatic breast cancer. Established in 2012, Aclaris Therapeutics, Inc. has its corporate headquarters situated in Wayne, Pennsylvania.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD5.54
+0.11 (+2.03%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
0.80
Float Shares
104.53M
Free Float %
86.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.41% | +6.00% | +22.52% | +47.32% | +105.39% | +64.45% | +296.00% | -37.26% | -77.26% | -70.76% | -55.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (16 ratings, all time)
Buy
Price Targets & DCF
Current price
5.54
Low
10.00
+80.5%
Consensus
10.60
+91.3%
Median
10.00
+80.5%
High
12.00
+116.6%
Ratings Trend (MoM)
90% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 8 | +1 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 4 |
10.75
+94.0%
|
| Last Quarter | 4 |
10.75
+94.0%
|
| Last Year | 5 |
10.60
+91.3%
|
| All Time | 9 |
10.67
+92.6%
|
Quality scores
Altman Z-Score
-1.13
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
1 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-58.2% Q1'26: +37.2% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+69.0% ★ Q1'26: -25.0% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-791.1% Q1'26: -909.3% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-829.6% Q1'26: -1,111.8% (vs Q1'25)
-
ROIC Biotechnology: -16.1%-449.4% Q1'26: -220.7% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+58.7% Q1'26: +5.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.03× Q1'26: -0.02× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 8 Rev. Ana. 8 EPS Ana. |
Dec 2027 8 Rev. Ana. 8 EPS Ana. |
Dec 2028 7 Rev. Ana. 7 EPS Ana. |
Dec 2029 3 Rev. Ana. 2 EPS Ana. |
Dec 2030 6 Rev. Ana. 5 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.68M
est: 1.21M (+38.6%)
|
10.09M
est: 10.14M (-0.5%)
|
4.23M
est: 22.59M (-81.3%)
|
6.48M
est: 6.29M (+3.0%)
|
6.76M
est: 7.05M (-4.1%)
|
29.75M
est: 23.99M (+24.0%)
|
31.25M
est: 32.02M (-2.4%)
|
18.72M
est: 11.61M (+61.3%)
|
7.83M
est: 8.76M (-10.7%)
|
5.81M
912.3K – 10.14M
-33.7% YoY
|
5.93M
904.8K – 12.06M
+2.1% YoY
|
6.90M
1.07M – 13.05M
+16.3% YoY
|
28.37M
4.39M – 53.66M
+311.3% YoY
|
114.38M
17.70M – 216.37M
+303.2% YoY
|
| EBITDA |
-53.45M
est: -1.21M (-4,303.0%)
|
-80.78M
est: -10.14M (-696.8%)
|
-90.23M
est: -112.87M (+20.1%)
|
-47.20M
est: -50.11M (+5.8%)
|
-64.46M
est: -76.78M (+16.0%)
|
-84.36M
est: -86.31M (+2.3%)
|
-115.45M
est: -32.02M (-260.6%)
|
-51.72M
est: -11.61M (-345.5%)
|
-64.47M
est: -8.76M (-635.8%)
|
-5.81M
-10.14M – -912.3K
+33.7% YoY
|
-5.93M
-12.06M – -904.8K
-2.1% YoY
|
-6.90M
-13.05M – -1.07M
-16.3% YoY
|
-28.37M
-53.66M – -4.39M
-311.3% YoY
|
-114.38M
-216.37M – -17.70M
-303.2% YoY
|
| EBIT |
-53.36M
est: -1.21M (-4,295.5%)
|
-84.78M
est: -10.14M (-736.2%)
|
-91.82M
est: -88.79M (-3.4%)
|
-48.52M
est: -51.26M (+5.3%)
|
-65.38M
est: -76.72M (+14.8%)
|
-85.15M
est: -87.26M (+2.4%)
|
-116.31M
est: -32.02M (-263.3%)
|
-52.53M
est: -11.61M (-352.5%)
|
-64.92M
est: -8.76M (-641.0%)
|
-5.81M
-10.14M – -912.3K
+33.7% YoY
|
-5.93M
-12.06M – -904.8K
-2.1% YoY
|
-6.90M
-13.05M – -1.07M
-16.3% YoY
|
-28.37M
-53.66M – -4.39M
-311.3% YoY
|
-114.38M
-216.37M – -17.70M
-303.2% YoY
|
| Net Income |
-68.52M
est: -187.28M (+63.4%)
|
-132.74M
est: -406.84M (+67.4%)
|
-161.35M
est: -117.45M (-37.4%)
|
-51.02M
est: -51.47M (+0.9%)
|
-90.87M
est: -77.55M (-17.2%)
|
-86.91M
est: -105.32M (+17.5%)
|
-88.48M
est: -58.68M (-50.8%)
|
-132.07M
est: -134.65M (+1.9%)
|
-64.92M
est: -65.12M (+0.3%)
|
-85.05M
-89.42M – -62.20M
-30.6% YoY
|
-102.02M
-103.92M – -55.02M
-19.9% YoY
|
-119.43M
-122.38M – -38.83M
-17.1% YoY
|
-102.69M
-221.72M – 10.15M
+14.0% YoY
|
-85.87M
-185.40M – 8.48M
+16.4% YoY
|
| SGA |
33.11M
est: 2.35M (+1,307.7%)
|
75.65M
est: 19.64M (+285.1%)
|
27.83M
est: 43.76M (-36.4%)
|
20.53M
est: 12.19M (+68.3%)
|
23.62M
est: 13.66M (+72.9%)
|
25.13M
est: 46.48M (-45.9%)
|
31.10M
est: 59.72M (-47.9%)
|
22.20M
est: 21.66M (+2.5%)
|
21.97M
est: 16.34M (+34.4%)
|
10.83M
1.70M – 18.91M
-33.7% YoY
|
11.06M
1.69M – 22.50M
+2.1% YoY
|
12.87M
1.99M – 24.34M
+16.3% YoY
|
52.92M
8.19M – 100.11M
+311.3% YoY
|
213.36M
33.02M – 403.61M
+303.2% YoY
|
| EPS |
-2.44
est: -2.42 (-0.7%)
|
-4.03
est: -5.26 (+23.4%)
|
-3.46
est: -3.46 (+0.0%)
|
-1.20
est: -1.84 (+34.8%)
|
-1.60
est: -1.61 (+0.4%)
|
-1.33
est: -1.44 (+7.5%)
|
-1.27
est: -0.83 (-53.7%)
|
-1.71
est: -0.82 (-108.5%)
|
-0.53
est: -0.53 (-0.8%)
|
-0.66
-0.73 – -0.51
-24.6% YoY
|
-0.67
-0.85 – -0.45
-2.0% YoY
|
-0.77
-1.00 – -0.32
-15.9% YoY
|
-0.84
-1.81 – 0.08
-8.1% YoY
|
-0.70
-1.51 – 0.07
+16.4% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-05 | Piper Sandler | Overweight | Overweight | Maintain |
| 2026-04-29 | Wedbush | Outperform | Outperform | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-01 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-53.04M
OE per share TTM
-0.43
Owner's Yield
-8.47%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
8.7%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
19
Total invested
1.87M
Insider transactions (90d)
2
Beneficial owners (>5%)
17
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Biosion, Inc. | 11.28M | 9.50% | 11.28M | — | 11.28M | — | CO | The People’s Republic of China | 2024-11-25 | ↗ |
| 2 | Vivo Opportunity Fund Holdings, L.P. | 7.96M | 7.40% | 7.96M | — | 7.96M | — | PN | Delaware | 2024-11-21 | ↗ |
| 3 | Vivo Opportunity, LLC | 7.96M | 7.40% | 7.96M | — | 7.96M | — | OO | Delaware | 2024-11-21 | ↗ |
| 4 | Rock Springs Capital Management LP | 6.76M | 6.32% | — | 6.76M | — | 6.76M | IA | Delaware | 2024-11-22 | ↗ |
| 5 | The Vanguard Group - 23-1945930 | 4.72M | 6.67% | — | 123.0K | 4.55M | 170.7K | IA | Pennsylvania | 2024-02-13 | ↗ |
| 6 | BML Investment Partners, L.P. | 4.50M | 6.40% | — | 4.50M | — | 4.50M | PN | Delaware | 2024-01-16 | ↗ |
| 7 | BVF Inc. | 3.36M | 5.00% | — | — | — | 3.36M | CO | Delaware | 2023-03-16 | ↗ |
| 8 | Mark N. Lampert | 3.36M | 5.00% | — | — | — | 3.36M | IN | Delaware | 2023-03-16 | ↗ |
| 9 | BVF GP Holdings LLC | 3.16M | 4.70% | — | — | — | 3.16M | OO | Delaware | 2023-03-16 | ↗ |
| 10 | Israel A. Englander | 3.01M | 4.20% | — | 3.01M | — | 3.01M | IN | Delaware | 2024-10-09 | ↗ |
| 11 | Millennium Group Management LLC | 3.01M | 4.20% | — | 3.01M | — | 3.01M | OO | Delaware | 2024-10-09 | ↗ |
| 12 | Millennium Management LLC | 3.01M | 4.20% | — | 3.01M | — | 3.01M | OO | Delaware | 2024-10-09 | ↗ |
| 13 | Vivo Asia Opportunity Fund Holdings, L.P. | 933.7K | 0.90% | 933.7K | — | 933.7K | — | PN | Delaware | 2024-11-21 | ↗ |
| 14 | Vivo Opportunity Cayman, LLC | 933.7K | 0.90% | 933.7K | — | 933.7K | — | OO | Delaware | 2024-11-21 | ↗ |
| 15 | BVF Partners OS Ltd. | 156.1K | 1.00% | — | — | — | 156.1K | CO | Delaware | 2023-03-16 | ↗ |
| 16 | Biotechnology Value Trading Fund OS LP | 156.1K | 1.00% | — | — | — | 156.1K | PN | Delaware | 2023-03-16 | ↗ |
| 17 | 2. | 10.00 | 5.10% | — | 3.59M | — | — | HC, IN | Delaware | 2023-09-05 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
19
-104 vs prev Q
New positions
4
Closed positions
106
Increased
9
Reduced
5
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | BML CAPITAL MANAGEMENT, LLC | 14.25M +— (+0.0%) | 42.89M +15.8M (+58.4%) | 11.62% -0.004 pp | 37.08% +12.285 pp | USD1.21 +148.8% | 9 qtrs — |
| 2 | VIVO CAPITAL, LLC | 8.89M +— (+0.0%) | 26.76M +9.9M (+58.4%) | 7.25% -0.002 pp | 1.73% +0.370 pp | USD2.48 +21.4% | 5 qtrs — |
| 3 | BLACKROCK, INC. | 6.80M +1.1M (+19.6%) | 20.48M +9.7M (+89.4%) | 5.55% +0.907 pp | 0.00% +0.000 pp | USD1.64 +83.5% | 6 qtrs — |
| 4 | VANGUARD GROUP INC | 6.50M -13.4K (-0.2%) | 19.57M +7.2M (+58.1%) | 5.30% -0.013 pp | 0.00% +0.000 pp | USD7.68 -60.8% | 41 qtrs — |
| 5 | ROCK SPRINGS CAPITAL MANAGEMENT LP | 4.45M -155.6K (-3.4%) | 13.41M +4.6M (+53.1%) | 3.63% -0.128 pp | 0.69% +0.176 pp | USD6.82 -55.9% | 41 qtrs — |
| 6 | DECHENG CAPITAL LLC | 4.04M +— (+0.0%) | 12.17M +4.5M (+58.4%) | 3.30% -0.001 pp | 1.64% +0.297 pp | USD2.06 +46.1% | 5 qtrs — |
| 7 | MORGAN STANLEY | 3.42M -661.9K (-16.2%) | 10.28M +2.5M (+32.7%) | 2.79% -0.541 pp | 0.00% +0.000 pp | USD2.04 +47.5% | 41 qtrs — |
| 8 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 3.37M -1.9M (-36.1%) | 10.15M +118.2K (+1.2%) | 2.75% -1.557 pp | 0.02% -0.001 pp | USD2.48 +21.4% | 5 qtrs — |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 2.39M +3.2K (+0.1%) | 7.20M +2.7M (+58.6%) | 1.95% +0.002 pp | 0.00% +0.000 pp | USD4.75 -36.6% | 41 qtrs — |
| 10 | ACADIAN ASSET MANAGEMENT LLC | 2.12M -204.6K (-8.8%) | 6.39M +2.0M (+44.6%) | 1.73% -0.168 pp | 0.01% +0.003 pp | USD1.18 +155.1% | 9 qtrs — |
| 11 | D. E. SHAW & CO., INC. | 2.10M -276.6K (-11.7%) | 6.31M +1.8M (+40.0%) | 1.71% -0.226 pp | 0.00% +0.001 pp | USD1.28 +135.2% | 11 qtrs — |
| 12 | KOTLER KEVIN | 1.71M +1.7M (+100.0%) | 5.13M +5.1M (+100.0%) | 1.39% +1.391 pp | 1.20% +1.201 pp | USD3.01 +0.0% | 1 qtrs NEW |
| 13 | PALO ALTO INVESTORS LP | 1.57M +— (+0.0%) | 4.72M +1.7M (+58.4%) | 1.28% 0.000 pp | 0.66% +0.106 pp | USD1.43 +110.5% | 8 qtrs — |
| 14 | STATE STREET CORP | 1.51M +393.3K (+35.3%) | 4.53M +2.4M (+114.4%) | 1.23% +0.320 pp | 0.00% +0.000 pp | USD3.80 -20.8% | 41 qtrs — |
| 15 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 1.43M +366.5K (+34.3%) | 4.32M +2.3M (+112.8%) | 1.17% +0.299 pp | 0.01% +0.005 pp | USD2.24 +34.4% | 14 qtrs — |
| 16 | CITADEL ADVISORS LLC | 1.21M -227.4K (-15.9%) | 3.63M +905.8K (+33.3%) | 0.98% -0.186 pp | 0.00% +0.000 pp | USD1.85 +62.7% | 38 qtrs — |
| 17 | RENAISSANCE TECHNOLOGIES LLC | 1.13M -494.4K (-30.5%) | 3.39M +309.8K (+10.1%) | 0.92% -0.404 pp | 0.01% +0.001 pp | USD1.52 +98.0% | 29 qtrs — |
| 18 | MILLENNIUM MANAGEMENT LLC | 1.05M -501.2K (-32.2%) | 3.17M +216.8K (+7.3%) | 0.86% -0.409 pp | 0.00% +0.000 pp | USD3.25 -7.4% | 28 qtrs — |
| 19 | DEUTSCHE BANK AG\ | 987.4K +64.0K (+6.9%) | 2.97M +1.2M (+69.4%) | 0.81% +0.052 pp | 0.00% +0.000 pp | USD3.49 -13.8% | 41 qtrs — |
| 20 | ALDEBARAN CAPITAL, LLC | 954.3K -33.4K (-3.4%) | 2.87M +995.7K (+53.1%) | 0.78% -0.028 pp | 2.58% +0.852 pp | USD1.15 +161.7% | 7 qtrs — |
| 21 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 916.8K +880.6K (+2,430.1%) | 2.76M +2.7M (+3,908.3%) | 0.75% +0.718 pp | 0.00% +0.000 pp | USD2.96 +1.7% | 21 qtrs — |
| 22 | BOLLARD GROUP LLC | 804.4K -421.0K (-34.4%) | 2.42M +93.0K (+4.0%) | 0.66% -0.344 pp | 0.06% +0.006 pp | USD1.53 +96.7% | 4 qtrs — |
| 23 | WOODLINE PARTNERS LP | 742.0K +742.0K (+100.0%) | 2.23M +2.2M (+100.0%) | 0.61% +0.605 pp | 0.01% +0.009 pp | USD3.01 +0.0% | 1 qtrs NEW |
| 24 | THREE BRIDGE WEALTH ADVISORS, LLC | 714.8K +— (+0.0%) | 2.15M +793.5K (+58.4%) | 0.58% 0.000 pp | 0.57% +0.217 pp | USD1.90 +58.4% | 2 qtrs — |
| 25 | NORTHERN TRUST CORP | 664.3K -36.6K (-5.2%) | 2.00M +667.9K (+50.2%) | 0.54% -0.030 pp | 0.00% +0.000 pp | USD4.03 -25.3% | 41 qtrs — |
| 26 | GOLDMAN SACHS GROUP INC | 632.5K -323.5K (-33.8%) | 1.90M +87.3K (+4.8%) | 0.52% -0.264 pp | 0.00% +0.000 pp | USD1.95 +54.4% | 36 qtrs — |
| 27 | JPMORGAN CHASE & CO | 626.0K -132.6K (-17.5%) | 1.88M +442.9K (+30.7%) | 0.51% -0.108 pp | 0.00% +0.000 pp | USD1.82 +65.4% | 20 qtrs — |
| 28 | ADAR1 CAPITAL MANAGEMENT, LLC | 614.0K +240.3K (+64.3%) | 1.85M +1.1M (+160.3%) | 0.50% +0.196 pp | 0.14% +0.069 pp | USD2.33 +29.2% | 2 qtrs — |
| 29 | LOGOS GLOBAL MANAGEMENT LP | 600.0K -900.0K (-60.0%) | 1.81M -1.0M (-36.6%) | 0.49% -0.734 pp | 0.11% -0.146 pp | USD2.48 +21.4% | 5 qtrs — |
| 30 | TWO SIGMA INVESTMENTS, LP | 574.2K +206.1K (+56.0%) | 1.73M +1.0M (+147.1%) | 0.47% +0.168 pp | 0.00% +0.001 pp | USD1.82 +65.4% | 13 qtrs — |
| 31 | MARSHALL WACE, LLP | 485.5K -1.2M (-71.7%) | 1.46M -1.8M (-55.2%) | 0.40% -1.006 pp | 0.00% -0.002 pp | USD2.48 +21.4% | 5 qtrs — |
| 32 | QUBE RESEARCH & TECHNOLOGIES LTD | 447.2K -97.6K (-17.9%) | 1.35M +311.0K (+30.0%) | 0.36% -0.080 pp | 0.00% +0.000 pp | USD1.67 +80.2% | 9 qtrs — |
| 33 | AISLING CAPITAL MANAGEMENT LP | 434.5K +— (+0.0%) | 1.31M +482.2K (+58.4%) | 0.35% 0.000 pp | 0.27% +0.092 pp | USD7.39 -59.3% | 29 qtrs — |
| 34 | UBS GROUP AG | 362.5K +257.4K (+244.8%) | 1.09M +891.5K (+446.3%) | 0.30% +0.210 pp | 0.00% +0.000 pp | USD2.72 +10.7% | 29 qtrs — |
| 35 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 330.0K -63.3K (-16.1%) | 993.4K +246.1K (+32.9%) | 0.27% -0.052 pp | 0.02% +0.005 pp | USD1.50 +100.7% | 7 qtrs — |
| 36 | AMERIPRISE FINANCIAL INC | 318.4K -959.4K (-75.1%) | 958.5K -1.5M (-60.5%) | 0.26% -0.783 pp | 0.00% 0.000 pp | USD1.90 +58.4% | 2 qtrs — |
| 37 | HIGHTOWER ADVISORS, LLC | 305.9K -3.4K (-1.1%) | 920.9K +333.2K (+56.7%) | 0.25% -0.003 pp | 0.00% +0.000 pp | USD11.64 -74.1% | 39 qtrs — |
| 38 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 284.6K +42.6K (+17.6%) | 856.7K +396.9K (+86.3%) | 0.23% +0.035 pp | 0.00% +0.000 pp | USD1.77 +70.1% | 41 qtrs — |
| 39 | DIMENSIONAL FUND ADVISORS LP | 270.9K +106.6K (+64.9%) | 814.6K +502.5K (+161.0%) | 0.22% +0.087 pp | 0.00% +0.000 pp | USD3.27 -8.0% | 14 qtrs — |
| 40 | RAYMOND JAMES FINANCIAL INC | 269.7K -13.8K (-4.9%) | 811.7K +273.1K (+50.7%) | 0.22% -0.011 pp | 0.00% +0.000 pp | USD2.05 +46.8% | 5 qtrs — |
| 41 | WELLINGTON MANAGEMENT GROUP LLP | 264.4K +264.4K (+100.0%) | 795.7K +795.7K (+100.0%) | 0.22% +0.216 pp | 0.00% +0.000 pp | USD3.01 +0.0% | 1 qtrs NEW |
| 42 | TWO SIGMA ADVISERS, LP | 255.4K -94.7K (-27.0%) | 768.8K +103.6K (+15.6%) | 0.21% -0.077 pp | 0.00% +0.000 pp | USD1.66 +81.3% | 12 qtrs — |
| 43 | NUVEEN, LLC | 237.8K +— (+0.0%) | 715.9K +264.0K (+58.4%) | 0.19% 0.000 pp | 0.00% +0.000 pp | USD1.42 +112.0% | 3 qtrs — |
| 44 | INVESCO LTD. | 209.9K +47.4K (+29.2%) | 631.8K +323.1K (+104.7%) | 0.17% +0.039 pp | 0.00% +0.000 pp | USD1.92 +56.8% | 5 qtrs — |
| 45 | BANK OF NEW YORK MELLON CORP | 203.5K -16.6K (-7.5%) | 612.6K +194.4K (+46.5%) | 0.17% -0.014 pp | 0.00% +0.000 pp | USD1.44 +109.0% | 4 qtrs — |
| 46 | ASSENAGON ASSET MANAGEMENT S.A. | 154.6K +— (+0.0%) | 465.2K +171.6K (+58.4%) | 0.13% +0.000 pp | 0.00% +0.000 pp | USD1.72 +75.0% | 6 qtrs — |
| 47 | BARCLAYS PLC | 143.4K +123.0K (+603.3%) | 431.7K +408.2K (+1,740.7%) | 0.12% +0.100 pp | 0.00% +0.000 pp | USD2.89 +4.2% | 19 qtrs — |
| 48 | PRICE T ROWE ASSOCIATES INC /MD/ | 140.2K +— (+0.0%) | 422.0K +155.0K (+58.1%) | 0.11% +0.000 pp | 0.00% +0.000 pp | USD7.31 -58.8% | 20 qtrs — |
| 49 | XTX TOPCO LTD | 112.9K +49.0K (+76.6%) | 339.9K +218.4K (+179.8%) | 0.09% +0.040 pp | 0.01% +0.003 pp | USD2.28 +32.0% | 9 qtrs — |
| 50 | — | 107.4K +107.4K (+100.0%) | 323.3K +323.3K (+100.0%) | 0.09% +0.088 pp | 0.25% +0.246 pp | USD3.01 +0.0% | 1 qtrs NEW |
| 51 | WELLS FARGO & COMPANY/MN | 104.5K +36.4K (+53.5%) | 314.4K +185.2K (+143.2%) | 0.09% +0.030 pp | 0.00% +0.000 pp | USD2.30 +30.9% | 41 qtrs — |
| 52 | AQR CAPITAL MANAGEMENT LLC | 103.8K +68.8K (+197.0%) | 312.4K +246.0K (+370.4%) | 0.08% +0.056 pp | 0.00% +0.000 pp | USD2.64 +14.0% | 2 qtrs — |
| 53 | ALPS ADVISORS INC | 89.0K +89.0K (+100.0%) | 267.8K +267.8K (+100.0%) | 0.07% +0.073 pp | 0.00% +0.002 pp | USD3.01 +0.0% | 1 qtrs NEW |
| 54 | POINT72 ASSET MANAGEMENT, L.P. | 87.2K +87.2K (+100.0%) | 262.4K +262.4K (+100.0%) | 0.07% +0.071 pp | 0.00% +0.000 pp | USD3.01 +0.0% | 1 qtrs NEW |
| 55 | AMERICAN CENTURY COMPANIES INC | 77.6K +45.8K (+144.0%) | 233.5K +173.1K (+286.6%) | 0.06% +0.037 pp | 0.00% +0.000 pp | USD2.56 +17.6% | 2 qtrs — |
| 56 | RHUMBLINE ADVISERS | 71.8K -19.4K (-21.3%) | 216.1K +42.8K (+24.7%) | 0.06% -0.016 pp | 0.00% +0.000 pp | USD1.45 +107.6% | 3 qtrs — |
| 57 | PANAGORA ASSET MANAGEMENT INC | 68.2K +22.6K (+49.6%) | 205.3K +118.6K (+137.0%) | 0.06% +0.018 pp | 0.00% +0.000 pp | USD2.27 +32.6% | 2 qtrs — |
| 58 | BANK OF AMERICA CORP /DE/ | 64.5K -10.7K (-14.2%) | 194.2K +51.3K (+35.9%) | 0.05% -0.009 pp | 0.00% +0.000 pp | USD2.56 +17.6% | 19 qtrs — |
| 59 | QUADRATURE CAPITAL LTD | 57.7K +26.1K (+82.8%) | 173.6K +114.0K (+191.1%) | 0.05% +0.021 pp | 0.00% +0.001 pp | USD2.20 +36.8% | 4 qtrs — |
| 60 | CREATIVE PLANNING | 51.2K +51.2K (+100.0%) | 154.0K +154.0K (+100.0%) | 0.04% +0.042 pp | 0.00% +0.000 pp | USD3.01 +0.0% | 1 qtrs NEW |
| 61 | INTECH INVESTMENT MANAGEMENT LLC | 46.6K +7.7K (+19.8%) | 140.4K +66.4K (+89.8%) | 0.04% +0.006 pp | 0.00% +0.001 pp | USD1.68 +79.2% | 3 qtrs — |
| 62 | FMR LLC | 45.8K +5.5K (+13.5%) | 137.9K +61.2K (+79.8%) | 0.04% +0.004 pp | 0.00% +0.000 pp | USD20.30 -85.2% | 41 qtrs — |
| 63 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 42.6K -187.0 (-0.4%) | 128.1K +46.9K (+57.7%) | 0.03% 0.000 pp | 0.00% +0.000 pp | USD1.42 +112.0% | 3 qtrs — |
| 64 | MAN GROUP PLC | 42.4K +42.4K (+100.0%) | 127.7K +127.7K (+100.0%) | 0.03% +0.035 pp | 0.00% +0.000 pp | USD3.01 +0.0% | 1 qtrs NEW |
| 65 | CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 41.9K +— (+0.0%) | 126.0K +46.0K (+57.5%) | 0.03% +0.000 pp | 0.00% +0.000 pp | USD1.39 +116.5% | 26 qtrs — |
| 66 | CITIGROUP INC | 41.6K +39.7K (+2,051.4%) | 125.3K +121.6K (+3,308.8%) | 0.03% +0.032 pp | 0.00% +0.000 pp | USD2.95 +2.0% | 21 qtrs — |
| 67 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 39.7K +39.7K (+100.0%) | 119.5K +119.5K (+100.0%) | 0.03% +0.032 pp | 0.00% +0.002 pp | USD3.01 +0.0% | 1 qtrs NEW |
| 68 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 29.0K -4.5K (-13.4%) | 87.3K +23.6K (+37.1%) | 0.02% -0.004 pp | 0.00% +0.000 pp | USD1.42 +112.0% | 3 qtrs — |
| 69 | VALEO FINANCIAL ADVISORS, LLC | 27.5K +27.5K (+100.0%) | 82.9K +82.9K (+100.0%) | 0.02% +0.023 pp | 0.00% +0.002 pp | USD3.01 +0.0% | 1 qtrs NEW |
| 70 | NEW YORK STATE COMMON RETIREMENT FUND | 27.3K -21.1K (-43.6%) | 82.2K -9.8K (-10.6%) | 0.02% -0.017 pp | 0.00% +0.000 pp | USD1.42 +112.0% | 3 qtrs — |
| 71 | JANE STREET GROUP, LLC | 27.2K -45.9K (-62.8%) | 81.9K -57.0K (-41.0%) | 0.02% -0.037 pp | 0.00% +0.000 pp | USD1.90 +58.4% | 12 qtrs — |
| 72 | VONTOBEL HOLDING LTD. | 26.0K +— (+0.0%) | 78.3K +28.9K (+58.4%) | 0.02% +0.000 pp | 0.00% +0.000 pp | USD3.11 -3.2% | 12 qtrs — |
| 73 | METLIFE INVESTMENT MANAGEMENT, LLC | 25.6K -9.7K (-27.5%) | 77.0K +9.9K (+14.8%) | 0.02% -0.008 pp | 0.00% +0.000 pp | USD1.42 +112.0% | 3 qtrs — |
| 74 | AXQ CAPITAL, LP | 24.2K +10.2K (+73.1%) | 72.8K +46.3K (+174.3%) | 0.02% +0.008 pp | 0.02% +0.006 pp | USD2.37 +27.0% | 2 qtrs — |
| 75 | PERSISTENT ASSET PARTNERS LTD | 22.3K +22.3K (+100.0%) | 67.0K +67.0K (+100.0%) | 0.02% +0.018 pp | 0.03% +0.030 pp | USD3.01 +0.0% | 1 qtrs NEW |
| 76 | PROSHARE ADVISORS LLC | 21.6K +6.7K (+45.4%) | 64.9K +36.7K (+130.4%) | 0.02% +0.006 pp | 0.00% +0.000 pp | USD1.92 +56.8% | 3 qtrs — |
| 77 | BNP PARIBAS ARBITRAGE, SNC | 21.5K -5.2K (-19.3%) | 64.8K +14.1K (+27.8%) | 0.02% -0.004 pp | 0.00% +0.000 pp | USD1.72 +75.0% | 19 qtrs — |
| 78 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 19.7K +— (+0.0%) | 59.3K +21.9K (+58.4%) | 0.02% +0.000 pp | 0.00% +0.000 pp | USD1.42 +112.0% | 3 qtrs — |
| 79 | NEUBERGER BERMAN GROUP LLC | 19.0K +6.3K (+49.2%) | 57.1K +32.9K (+136.4%) | 0.02% +0.005 pp | 0.00% +0.000 pp | USD1.70 +77.1% | 9 qtrs — |
| 80 | CRA FINANCIAL SERVICES, LLC | 17.8K +— (+0.0%) | 53.5K +19.7K (+58.4%) | 0.01% +0.000 pp | 0.01% +0.002 pp | USD1.42 +112.0% | 3 qtrs — |
| 81 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 17.7K +17.7K (+100.0%) | 53.1K +53.1K (+100.0%) | 0.01% +0.014 pp | 0.00% +0.004 pp | USD3.01 +0.0% | 1 qtrs NEW |
| 82 | CIBC ASSET MANAGEMENT INC | 17.4K +17.4K (+100.0%) | 52.5K +52.5K (+100.0%) | 0.01% +0.014 pp | 0.00% +0.000 pp | USD3.01 +0.0% | 1 qtrs NEW |
| 83 | VOYA INVESTMENT MANAGEMENT LLC | 17.2K +— (+0.0%) | 51.9K +19.1K (+58.4%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD1.42 +112.0% | 3 qtrs — |
| 84 | SIMPLEX TRADING, LLC | 16.7K +16.7K (+100.0%) | 50.2K +50.2K (+100.0%) | 0.01% +0.014 pp | 0.00% +0.000 pp | USD3.01 +0.0% | 22 qtrs — |
| 85 | MARINER, LLC | 16.7K +558.0 (+3.5%) | 50.2K +19.5K (+63.8%) | 0.01% +0.001 pp | 0.00% +0.000 pp | USD1.15 +161.7% | 9 qtrs — |
| 86 | SG AMERICAS SECURITIES, LLC | 15.4K -6.6K (-29.9%) | 46.0K +4.0K (+9.5%) | 0.01% -0.005 pp | 0.00% 0.000 pp | USD1.53 +96.7% | 4 qtrs — |
| 87 | ALLIANCEBERNSTEIN L.P. | 15.2K +— (+0.0%) | 45.8K +16.9K (+58.4%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD1.42 +112.0% | 3 qtrs — |
| 88 | GROUP ONE TRADING, L.P. | 12.4K +10.7K (+611.3%) | 37.4K +34.1K (+1,026.9%) | 0.01% +0.009 pp | 0.00% +0.000 pp | USD2.79 +7.9% | 3 qtrs — |
| 89 | R SQUARED LTD | 12.4K +12.4K (+100.0%) | 37.3K +37.3K (+100.0%) | 0.01% +0.010 pp | 0.02% +0.018 pp | USD3.01 +0.0% | 1 qtrs NEW |
| 90 | TWO SIGMA SECURITIES, LLC | 11.5K +959.0 (+9.1%) | 34.8K +14.6K (+72.8%) | 0.01% +0.001 pp | 0.00% +0.002 pp | USD1.99 +51.3% | 2 qtrs — |
| 91 | JEFFERIES FINANCIAL GROUP INC. | 11.0K +2.0 (+0.0%) | 33.1K +12.2K (+58.4%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD3.97 -24.2% | 12 qtrs — |
| 92 | VICTORY CAPITAL MANAGEMENT INC | 10.7K +23.0 (+0.2%) | 32.1K +11.9K (+58.8%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD1.53 +96.7% | 4 qtrs — |
| 93 | MERCER GLOBAL ADVISORS INC /ADV | 10.2K -293.0 (-2.8%) | 30.6K +10.7K (+54.0%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD1.54 +95.5% | 4 qtrs — |
| 94 | RUSSELL INVESTMENTS GROUP, LTD. | 9.8K +173.0 (+1.8%) | 29.5K +11.2K (+61.3%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD1.87 +61.0% | 10 qtrs — |
| 95 | AMERITAS INVESTMENT PARTNERS, INC. | 9.3K +— (+0.0%) | 27.9K +10.3K (+58.4%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD1.42 +112.0% | 3 qtrs — |
| 96 | LEGAL & GENERAL GROUP PLC | 8.2K +— (+0.0%) | 24.8K +9.1K (+58.4%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD1.42 +112.0% | 3 qtrs — |
| 97 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 5.6K -19.0 (-0.3%) | 17.0K +6.2K (+57.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.42 +112.0% | 3 qtrs — |
| 98 | STERLING CAPITAL MANAGEMENT LLC | 5.3K -692.0 (-11.6%) | 15.9K +4.6K (+40.1%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD1.70 +77.1% | 3 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 75 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Pharmaceuticals ETF XPH | 0.92% | 4.32M | 0.35% |
| 2 | Invesco NASDAQ Future Gen 200 ETF QQQS | 0.61% | 134.5K | 0.20% |
| 3 | ALPS Medical Breakthroughs ETF SBIO | 0.40% | 851.0K | 0.50% |
| 4 | Direxion Daily Pharmaceutical & Medical Bull 3X ETF PILL | 0.19% | 44.4K | 1.22% |
| 5 | iShares Micro-Cap ETF IWC | 0.15% | 2.21M | 0.60% |
| 6 | Vanguard U.S. Momentum Factor ETF VFMO | 0.07% | 1.25M | 0.13% |
| 7 | iShares Nasdaq US Biotechnology UCITS ETF BTEE.L | 0.05% | 39.9K | 0.35% |
| 8 | iShares Nasdaq US Biotechnology UCITS ETF BTEC.L | 0.05% | 596.1K | 0.35% |
| 9 | Invesco NASDAQ Biotech UCITS ETF SBIO.L | 0.05% | 247.9K | 0.40% |
| 10 | Invesco Nasdaq Biotechnology ETF IBBQ | 0.05% | 40.0K | 0.19% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.09
Neutral
Ratio by volume
3.00
Bullish
Buys
25
Sells
23
Shares acquired
3.67M
Shares disposed
313.9K
Cash buys
—
Cash sales
—
Net activity
+3,356,222
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-01 | Hall Jesse Wayne | Officer | M-Exempt | D | Restricted Stock Units | 36,375 | 0.00 | — | 109,125 | D | ↗ |
| 2026-04-23 | Leonard Braden Michael | 10% Owner | S-Sale | D | Common Stock | 300,000 | 4.53 | 1.36M | 13,950,000 | I | ↗ |
| 2026-03-01 | Balthaser Kevin | Officer | M-Exempt | A | Common Stock | 2,375 | 0.00 | — | 188,130 | D | ↗ |
| 2026-02-03 | Walker Neal | Director / Officer | M-Exempt | D | Restricted Stock Units | 63,475 | 0.00 | — | 190,425 | D | ↗ |
| 2026-02-03 | Loerop James | Officer | F-InKind | D | Common Stock | 5,937 | 3.47 | 20.6K | 192,260 | D | ↗ |
| 2026-02-03 | Davis Hugh M. | Director / Officer | M-Exempt | D | Restricted Stock Units | 18,675 | 0.00 | — | 56,025 | D | ↗ |
| 2026-02-03 | Balthaser Kevin | Officer | F-InKind | D | Common Stock | 6,449 | 3.47 | 22.4K | 185,755 | D | ↗ |
| 2026-02-02 | Walker Neal | Director / Officer | A-Award | A | Restricted Stock Units | 274,800 | 0.00 | — | 274,800 | D | ↗ |
| 2026-02-02 | Loerop James | Officer | A-Award | A | Restricted Stock Units | 97,700 | 0.00 | — | 97,700 | D | ↗ |
| 2026-02-02 | Kolbeck Roland Wilhelm | Officer | A-Award | A | Restricted Stock Units | 95,700 | 0.00 | — | 95,700 | D | ↗ |
| 2026-02-02 | Hall Jesse Wayne | Officer | A-Award | A | Restricted Stock Units | 98,100 | 0.00 | — | 98,100 | D | ↗ |
| 2026-02-02 | Davis Hugh M. | Director / Officer | A-Award | A | Restricted Stock Units | 96,100 | 0.00 | — | 96,100 | D | ↗ |
| 2026-02-02 | Balthaser Kevin | Officer | A-Award | A | Restricted Stock Units | 99,100 | 0.00 | — | 99,100 | D | ↗ |
| 2026-02-01 | Loerop James | Officer | M-Exempt | D | Resticted Stock Units | 7,500 | 0.00 | — | 7,500 | D | ↗ |
| 2026-02-01 | Balthaser Kevin | Officer | M-Exempt | D | Restricted Stock Units | 14,750 | 0.00 | — | 29,500 | D | ↗ |
| 2026-01-02 | Walker Neal | Director / Officer | M-Exempt | D | Restricted Stock Units | 29,150 | 0.00 | — | 30,034 | D | ↗ |
| 2026-01-02 | Loerop James | Officer | M-Exempt | A | Common Stock | 18,150 | 0.00 | — | 161,212 | D | ↗ |
| 2026-01-02 | Balthaser Kevin | Officer | M-Exempt | A | Common Stock | 13,200 | 0.00 | — | 164,874 | D | ↗ |
| 2026-01-01 | Balthaser Kevin | Officer | M-Exempt | A | Common Stock | 7,500 | 0.00 | — | 153,924 | D | ↗ |
| 2025-12-31 | Loerop James | Officer | M-Exempt | D | Restricted Stock Units | 73,750 | 0.00 | — | 0 | D | ↗ |
| 2025-12-31 | Balthaser Kevin | Officer | F-InKind | D | Common Stock | 19,934 | 3.01 | 60.0K | 146,424 | D | ↗ |
| 2025-12-02 | Davis Hugh M. | Director / Officer | M-Exempt | D | Restricted Stock Units | 26,750 | 0.00 | — | 80,250 | D | ↗ |
| 2025-08-01 | Kolbeck Roland Wilhelm | Officer | A-Award | A | Employee Stock Option (right to buy) | 510,000 | 1.53 | 780.3K | 510,000 | D | ↗ |
| 2025-07-28 | Kolbeck Roland Wilhelm | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-06-06 | SCHIFF ANDREW N | Director | M-Exempt | D | Restricted Stock Units | 4,793 | 0.00 | — | 0 | D | ↗ |
| 2025-06-06 | Molineaux Christopher P. | Director | M-Exempt | A | Common Stock | 4,793 | 0.00 | — | 57,956 | D | ↗ |
| 2025-06-06 | Mehra Anand | Director | M-Exempt | D | Restricted Stock Units | 4,793 | 0.00 | — | 0 | D | ↗ |
| 2025-06-06 | MILANO VINCENT | Director | M-Exempt | D | Restricted Stock Units | 4,793 | 0.00 | — | 0 | D | ↗ |
| 2025-06-06 | Humphries William D. | Director | M-Exempt | A | Common Stock | 4,793 | 0.00 | — | 33,525 | D | ↗ |
| 2025-06-06 | GOWEN MAXINE | Director | M-Exempt | A | Common Stock | 4,793 | 0.00 | — | 21,754 | D | ↗ |
| 2025-06-05 | SCHIFF ANDREW N | Director | A-Award | A | Restricted Stock Units | 11,580 | 0.00 | — | 11,580 | D | ↗ |
| 2025-06-05 | Molineaux Christopher P. | Director | A-Award | A | Restricted Stock Units | 11,580 | 0.00 | — | 11,580 | D | ↗ |
| 2025-06-05 | Mehra Anand | Director | A-Award | A | Restricted Stock Units | 11,580 | 0.00 | — | 11,580 | D | ↗ |
| 2025-06-05 | MILANO VINCENT | Director | A-Award | A | Restricted Stock Units | 11,580 | 0.00 | — | 11,580 | D | ↗ |
| 2025-06-05 | Humphries William D. | Director | A-Award | A | Restricted Stock Units | 11,580 | 0.00 | — | 11,580 | D | ↗ |
| 2025-06-05 | GOWEN MAXINE | Director | A-Award | A | Restricted Stock Units | 11,580 | 0.00 | — | 11,580 | D | ↗ |
| 2025-05-01 | Walker Neal | Director / Officer | M-Exempt | D | Restricted Stock Units | 9,467 | 0.00 | — | 0 | D | ↗ |
| 2025-05-01 | Hall Jesse Wayne | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-04-01 | Walker Neal | Director / Officer | M-Exempt | A | Common Stock | 9,467 | 0.00 | — | 1,476,374 | D | ↗ |
| 2025-03-01 | Walker Neal | Director / Officer | M-Exempt | D | Restricted Stock Units | 9,466 | 0.00 | — | 18,934 | D | ↗ |
| 2025-03-01 | Monahan Joseph | Officer | M-Exempt | D | Restricted Stock Units | 50,000 | 0.00 | — | 0 | D | ↗ |
| 2025-03-01 | Balthaser Kevin | Officer | M-Exempt | D | Restricted Stock Units | 1,100 | 0.00 | — | 0 | D | ↗ |
| 2025-02-03 | Walker Neal | Director / Officer | A-Award | A | Restricted Stock Units | 253,900 | 0.00 | — | 253,900 | D | ↗ |
| 2025-02-03 | Monahan Joseph | Officer | A-Award | A | Restricted Stock Units | 83,900 | 0.00 | — | 83,900 | D | ↗ |
| 2025-02-03 | Loerop James | Officer | A-Award | A | Restricted Stock Units | 83,500 | 0.00 | — | 83,500 | D | ↗ |
| 2025-02-03 | Davis Hugh M. | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 261,600 | 2.40 | 627.8K | 261,600 | D | ↗ |
| 2025-02-03 | Balthaser Kevin | Officer | A-Award | A | Restricted Stock Units | 88,100 | 0.00 | — | 88,100 | D | ↗ |
| 2025-02-01 | Walker Neal | Director / Officer | M-Exempt | D | Restricted Stock Units | 9,467 | 0.00 | — | 28,400 | D | ↗ |
| 2025-02-01 | Monahan Joseph | Officer | M-Exempt | A | Common Stock | 7,500 | 0.00 | — | 228,562 | D | ↗ |
| 2025-02-01 | Loerop James | Officer | M-Exempt | D | Resticted Stock Units | 7,500 | 0.00 | — | 15,000 | D | ↗ |
| 2025-02-01 | Balthaser Kevin | Officer | M-Exempt | D | Restricted Stock Units | 14,750 | 0.00 | — | 44,250 | D | ↗ |
| 2025-01-02 | Walker Neal | Director / Officer | M-Exempt | A | Common Stock | 29,149 | 0.00 | — | 1,468,342 | D | ↗ |
| 2025-01-02 | Monahan Joseph | Officer | A-Award | A | Restricted Stock Units | 52,667 | 0.00 | — | 52,667 | D | ↗ |
| 2025-01-02 | Loerop James | Officer | F-InKind | D | Common Stock | 8,575 | 2.48 | 21.3K | 85,253 | D | ↗ |
| 2025-01-02 | Balthaser Kevin | Officer | M-Exempt | A | Common Stock | 13,200 | 0.00 | — | 85,985 | D | ↗ |
| 2025-01-01 | Walker Neal | Director / Officer | F-InKind | D | Common Stock | 3,904 | 2.48 | 9.7K | 1,439,193 | D | ↗ |
| 2025-01-01 | Balthaser Kevin | Officer | M-Exempt | A | Common Stock | 7,500 | 0.00 | — | 75,215 | D | ↗ |
| 2024-12-31 | Monahan Joseph | Officer | M-Exempt | D | Restricted Stock Units | 73,750 | 0.00 | — | 73,750 | D | ↗ |
| 2024-12-31 | Loerop James | Officer | M-Exempt | D | Restricted Stock Units | 73,750 | 0.00 | — | 73,750 | D | ↗ |
| 2024-12-31 | Balthaser Kevin | Officer | M-Exempt | A | Common Stock | 73,750 | 0.00 | — | 98,447 | D | ↗ |
| 2024-12-10 | Monahan Joseph | Officer | G-Gift | D | Common Stock | 15,000 | 0.00 | — | 171,783 | D | ↗ |
| 2024-12-04 | Walker Neal | Director / Officer | M-Exempt | A | Common Stock | 118,840 | 1.52 | 180.6K | 1,501,973 | D | ↗ |
| 2024-12-02 | Davis Hugh M. | Director / Officer | A-Award | A | Restricted Stock Units | 107,000 | 0.00 | — | 107,000 | D | ↗ |
| 2024-12-01 | Walker Neal | Director / Officer | M-Exempt | A | Common Stock | 9,466 | 0.00 | — | 1,385,854 | D | ↗ |
| 2024-11-19 | Mehra Anand | Director | P-Purchase | A | Common Stock | 666,666 | 2.25 | 1.50M | 710,030 | D | ↗ |
| 2024-11-18 | Davis Hugh M. | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-11-18 | Biosion, Inc. | 10% Owner | — | — | Warrants (right to buy) | 11,281,985 | 0.00 | 1.1K | 0 | D | ↗ |
| 2024-11-01 | Walker Neal | Director / Officer | F-InKind | D | Common Stock | 2,721 | 2.09 | 5.7K | 1,376,388 | D | ↗ |
| 2024-10-01 | Walker Neal | Director / Officer | M-Exempt | A | Common Stock | 9,467 | 0.00 | — | 1,372,364 | D | ↗ |
| 2024-09-01 | Walker Neal | Director / Officer | M-Exempt | A | Common Stock | 9,466 | 0.00 | — | 1,365,619 | — | ↗ |
| 2024-09-01 | Balthaser Kevin | Officer | M-Exempt | A | Common Stock | 1,000 | 0.00 | — | 24,983 | — | ↗ |
| 2024-08-09 | Walker Neal | Director / Officer | M-Exempt | D | Employee Stock Option (right to buy) | 43,548 | 0.72 | 31.4K | 0 | — | ↗ |
| 2024-08-05 | Leonard Braden Michael | 10% Owner | P-Purchase | A | Common Stock | 206,025 | 1.24 | 256.4K | 14,250,000 | — | ↗ |
| 2024-08-02 | Leonard Braden Michael | 10% Owner | P-Purchase | A | Common Stock | 167,544 | 1.29 | 216.4K | 14,043,975 | — | ↗ |
| 2024-08-01 | Walker Neal | Director / Officer | M-Exempt | D | Restricted Stock Units | 9,467 | 0.00 | — | 85,200 | — | ↗ |
| 2024-07-31 | Leonard Braden Michael | 10% Owner | P-Purchase | A | Common Stock | 100,000 | 1.33 | 132.6K | 13,876,421 | — | ↗ |
| 2024-07-30 | Leonard Braden Michael | 10% Owner | P-Purchase | A | Common Stock | 173,730 | 1.30 | 226.4K | 13,776,421 | — | ↗ |
| 2024-07-22 | Leonard Braden Michael | 10% Owner | P-Purchase | A | Common Stock | 17,716 | 1.33 | 23.6K | 13,602,691 | — | ↗ |
| 2024-07-19 | Leonard Braden Michael | 10% Owner | P-Purchase | A | Common Stock | 6,689 | 1.30 | 8.7K | 13,584,975 | — | ↗ |
| 2024-07-18 | Leonard Braden Michael | 10% Owner | P-Purchase | A | Common Stock | 130,317 | 1.30 | 169.6K | 13,578,286 | — | ↗ |
| 2024-07-05 | Leonard Braden Michael | 10% Owner | P-Purchase | A | Common Stock | 123,017 | 1.15 | 141.3K | 13,447,969 | — | ↗ |
| 2024-07-03 | Leonard Braden Michael | 10% Owner | P-Purchase | A | Common Stock | 143,288 | 1.16 | 166.1K | 13,324,952 | — | ↗ |
| 2024-07-02 | Leonard Braden Michael | 10% Owner | P-Purchase | A | Common Stock | 86,092 | 1.14 | 98.5K | 13,181,664 | — | ↗ |
| 2024-07-01 | Walker Neal | Director / Officer | M-Exempt | A | Common Stock | 9,467 | 0.00 | — | 1,308,582 | — | ↗ |
| 2024-07-01 | Leonard Braden Michael | 10% Owner | P-Purchase | A | Common Stock | 107,434 | 1.14 | 122.2K | 13,095,572 | — | ↗ |
| 2024-06-28 | Leonard Braden Michael | 10% Owner | P-Purchase | A | Common Stock | 801,000 | 1.12 | 896.6K | 12,588,134 | — | ↗ |
| 2024-06-27 | Leonard Braden Michael | 10% Owner | P-Purchase | A | Common Stock | 235,000 | 1.15 | 271.3K | 11,787,134 | — | ↗ |
| 2024-06-18 | Leonard Braden Michael | 10% Owner | P-Purchase | A | Common Stock | 50,000 | 1.13 | 56.5K | 11,552,134 | — | ↗ |
| 2024-06-17 | Leonard Braden Michael | 10% Owner | P-Purchase | A | Common Stock | 150,000 | 1.13 | 169.5K | 11,502,134 | — | ↗ |
| 2024-06-14 | Leonard Braden Michael | 10% Owner | P-Purchase | A | Common Stock | 345,000 | 1.17 | 402.2K | 11,352,134 | — | ↗ |
| 2024-06-13 | Leonard Braden Michael | 10% Owner | P-Purchase | A | Common Stock | 500,000 | 1.15 | 575.0K | 11,007,134 | — | ↗ |
| 2024-06-12 | Leonard Braden Michael | 10% Owner | P-Purchase | A | Common Stock | 82,579 | 1.14 | 94.1K | 10,478,513 | — | ↗ |
| 2024-06-11 | Leonard Braden Michael | 10% Owner | P-Purchase | A | Common Stock | 1,000,000 | 1.08 | 1.08M | 10,395,934 | — | ↗ |
| 2024-06-06 | SCHIFF ANDREW N | Director | A-Award | A | Restricted Stock Units | 4,793 | 0.00 | — | 4,793 | — | ↗ |
| 2024-06-06 | Molineaux Christopher P. | Director | A-Award | A | Stock Option (Right to Buy) | 15,750 | 1.03 | 16.2K | 15,750 | — | ↗ |
| 2024-06-06 | Mehra Anand | Director | A-Award | A | Stock Option (Right to Buy) | 15,750 | 1.03 | 16.2K | 15,750 | — | ↗ |
| 2024-06-06 | MILANO VINCENT | Director | A-Award | A | Stock Option (Right to Buy) | 15,750 | 1.03 | 16.2K | 15,750 | — | ↗ |
| 2024-06-06 | Humphries William D. | Director | A-Award | A | Restricted Stock Units | 4,793 | 0.00 | — | 4,793 | — | ↗ |
| 2024-06-06 | GOWEN MAXINE | Director | A-Award | A | Stock Option (Right to Buy) | 15,750 | 1.03 | 16.2K | 15,750 | — | ↗ |
| 2024-06-01 | Walker Neal | Director / Officer | M-Exempt | D | Restricted Stock Units | 9,466 | 0.00 | — | 104,134 | — | ↗ |
| 2024-06-01 | SCHIFF ANDREW N | Director | M-Exempt | D | Restricted Stock Units | 4,660 | 0.00 | — | 0 | — | ↗ |
| 2024-06-01 | Reasons Bryan M. | Director | M-Exempt | D | Restricted Stock Units | 4,660 | 0.00 | — | 0 | — | ↗ |
| 2024-06-01 | Powell Andrew Kenneth William | Director | M-Exempt | D | Restricted Stock Units | 4,660 | 0.00 | — | 0 | — | ↗ |
| 2024-06-01 | Molineaux Christopher P. | Director | M-Exempt | D | Restricted Stock Units | 4,660 | 0.00 | — | 0 | — | ↗ |
| 2024-06-01 | Mehra Anand | Director | M-Exempt | A | Common Stock | 4,660 | 0.00 | — | 43,364 | — | ↗ |
| 2024-06-01 | MILANO VINCENT | Director | M-Exempt | D | Restricted Stock Units | 4,660 | 0.00 | — | 0 | — | ↗ |
| 2024-06-01 | Humphries William D. | Director | M-Exempt | D | Restricted Stock Units | 4,660 | 0.00 | — | 0 | — | ↗ |
| 2024-06-01 | GOWEN MAXINE | Director | M-Exempt | D | Restricted Stock Units | 4,660 | 0.00 | — | 0 | — | ↗ |
| 2024-05-01 | Walker Neal | Director / Officer | M-Exempt | A | Common Stock | 9,467 | 0.00 | — | 1,295,155 | — | ↗ |
| 2024-04-01 | Walker Neal | Director / Officer | M-Exempt | D | Restricted Stock Units | 9,467 | 0.00 | — | 123,067 | — | ↗ |
| 2024-03-04 | Powell Andrew Kenneth William | Director | P-Purchase | A | Common Stock | 6,000 | 1.25 | 7.5K | 28,863 | — | ↗ |
| 2024-03-02 | Monahan Joseph | Officer | M-Exempt | A | Common Stock | 12,500 | 0.00 | — | 190,314 | — | ↗ |
| 2024-03-02 | Balthaser Kevin | Officer | F-InKind | D | Common Stock | 427 | 1.24 | 529.48 | 23,983 | — | ↗ |
| 2024-03-01 | Walker Neal | Director / Officer | F-InKind | D | Common Stock | 3,223 | 1.24 | 4.0K | 1,279,445 | — | ↗ |
| 2024-03-01 | Powell Andrew Kenneth William | Director | P-Purchase | A | Common Stock | 8,500 | 1.23 | 10.5K | 22,863 | — | ↗ |
| 2024-03-01 | Monahan Joseph | Officer | M-Exempt | D | Restricted Stock Units | 10,925 | 0.00 | — | 21,850 | — | ↗ |
| 2024-03-01 | Balthaser Kevin | Officer | M-Exempt | D | Restricted Stock Units | 1,100 | 0.00 | — | 1,100 | — | ↗ |
| 2024-02-07 | Leonard Braden Michael | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 9,395,934 | — | ↗ |
| 2024-02-01 | Walker Neal | Director / Officer | A-Award | A | Restricted Stock Units | 142,000 | 0.00 | — | 142,000 | — | ↗ |
| 2024-02-01 | Monahan Joseph | Officer | A-Award | A | Restricted Stock Units | 59,000 | 0.00 | — | 59,000 | — | ↗ |
| 2024-02-01 | Loerop James | Officer | A-Award | A | Restricted Stock Units | 147,500 | 0.00 | — | 147,500 | — | ↗ |
| 2024-02-01 | Balthaser Kevin | Officer | A-Award | A | Restricted Stock Units | 59,000 | 0.00 | — | 59,000 | — | ↗ |
| 2024-01-01 | Manion Douglas J. | Director / Officer | M-Exempt | D | Restricted Stock Units | 27,000 | 0.00 | — | 81,000 | — | ↗ |
| 2024-01-01 | Balthaser Kevin | Officer | F-InKind | D | Common Stock | 2,536 | 1.05 | 2.7K | 20,425 | — | ↗ |
| 2023-10-23 | Monahan Joseph | Officer | S-Sale | D | Common Stock | 6,000 | 5.08 | 30.5K | 129,724 | — | ↗ |
| 2023-09-06 | Balthaser Kevin | Officer | P-Purchase | A | Common Stock | 9,490 | 7.90 | 75.0K | 15,461 | — | ↗ |
| 2023-09-01 | Balthaser Kevin | Officer | M-Exempt | A | Common Stock | 1,000 | 0.00 | — | 6,256 | — | ↗ |
| 2023-08-28 | Loerop James | Officer | P-Purchase | A | Common Stock | 14,705 | 6.80 | 100.0K | 21,688 | — | ↗ |
| 2023-08-21 | Monahan Joseph | Officer | S-Sale | D | Common Stock | 6,000 | 7.32 | 43.9K | 135,724 | — | ↗ |
| 2023-08-01 | Manion Douglas J. | Director / Officer | M-Exempt | A | Common Stock | 15,575 | 0.00 | — | 28,375 | — | ↗ |
| 2023-07-01 | Cawkwell Gail | Officer | M-Exempt | A | Common Stock | 15,000 | 0.00 | — | 15,000 | — | ↗ |
| 2023-06-20 | Monahan Joseph | Officer | S-Sale | D | Common Stock | 6,000 | 10.28 | 61.7K | 141,724 | — | ↗ |
| 2023-06-20 | Molineaux Christopher P. | Director | M-Exempt | A | Common Stock | 16,500 | 1.41 | 23.3K | 48,503 | — | ↗ |
| 2023-06-15 | Molineaux Christopher P. | Director | M-Exempt | D | Stock Option (right to buy) | 51 | 0.72 | 36.72 | 0 | — | ↗ |
| 2023-06-02 | SCHIFF ANDREW N | Director | M-Exempt | D | Restricted Stock Units | 4,507 | 0.00 | — | 0 | — | ↗ |
| 2023-06-02 | Reasons Bryan M. | Director | M-Exempt | A | Common Stock | 4,507 | 0.00 | — | 24,072 | — | ↗ |
| 2023-06-02 | Powell Andrew Kenneth William | Director | M-Exempt | A | Common Stock | 4,507 | 0.00 | — | 14,363 | — | ↗ |
| 2023-06-02 | Molineaux Christopher P. | Director | M-Exempt | D | Restricted Stock Units | 4,507 | 0.00 | — | 0 | — | ↗ |
| 2023-06-02 | Mehra Anand | Director | M-Exempt | A | Common Stock | 4,507 | 0.00 | — | 38,704 | — | ↗ |
| 2023-06-02 | MILANO VINCENT | Director | M-Exempt | A | Common Stock | 4,507 | 0.00 | — | 7,863 | — | ↗ |
| 2023-06-02 | Humphries William D. | Director | M-Exempt | D | Restricted Stock Units | 4,507 | 0.00 | — | 0 | — | ↗ |
| 2023-06-02 | GOWEN MAXINE | Director | M-Exempt | D | Restricted Stock Units | 4,507 | 0.00 | — | 0 | — | ↗ |
| 2023-06-01 | SCHIFF ANDREW N | Director | A-Award | A | Restricted Stock Units | 4,660 | 0.00 | — | 4,660 | — | ↗ |
| 2023-06-01 | Reasons Bryan M. | Director | A-Award | A | Restricted Stock Units | 4,660 | 0.00 | — | 4,660 | — | ↗ |
| 2023-06-01 | Powell Andrew Kenneth William | Director | A-Award | A | Stock Option (Right to Buy) | 15,750 | 8.70 | 137.0K | 15,750 | — | ↗ |
| 2023-06-01 | Molineaux Christopher P. | Director | A-Award | A | Stock Option (Right to Buy) | 15,750 | 8.70 | 137.0K | 15,750 | — | ↗ |
| 2023-06-01 | Mehra Anand | Director | A-Award | A | Restricted Stock Units | 4,660 | 0.00 | — | 4,660 | — | ↗ |
| 2023-06-01 | MILANO VINCENT | Director | A-Award | A | Stock Option (Right to Buy) | 15,750 | 8.70 | 137.0K | 15,750 | — | ↗ |
| 2023-06-01 | Humphries William D. | Director | A-Award | A | Stock Option (Right to Buy) | 15,750 | 8.70 | 137.0K | 15,750 | — | ↗ |
| 2023-06-01 | GOWEN MAXINE | Director | A-Award | A | Restricted Stock Units | 4,660 | 0.00 | — | 4,660 | — | ↗ |
| 2023-03-17 | Manion Douglas J. | Director / Officer | P-Purchase | A | Common Stock | 6,300 | 7.86 | 49.5K | 12,800 | — | ↗ |
| 2023-03-09 | Manion Douglas J. | Director / Officer | P-Purchase | A | Common Stock | 6,500 | 7.74 | 50.3K | 6,500 | — | ↗ |
| 2023-03-03 | Walker Neal | Director | S-Sale | D | Common Stock | 30,240 | 12.63 | 382.1K | 1,273,202 | — | ↗ |
| 2023-03-03 | Monahan Joseph | Officer | S-Sale | D | Common Stock | 16,037 | 12.63 | 202.6K | 147,724 | — | ↗ |
| 2023-03-03 | Balthaser Kevin | Officer | S-Sale | D | Common Stock | 894 | 12.63 | 11.3K | 5,256 | — | ↗ |
| 2023-03-02 | Walker Neal | Director | M-Exempt | D | Restricted Stock Units | 18,254 | 0.00 | — | 18,254 | — | ↗ |
| 2023-03-02 | Monahan Joseph | Officer | M-Exempt | D | Restricted Stock Units | 12,500 | 0.00 | — | 12,500 | — | ↗ |
| 2023-03-02 | Balthaser Kevin | Officer | M-Exempt | D | Restricted Stock Units | 1,500 | 0.00 | — | 1,500 | — | ↗ |
| 2023-03-01 | Walker Neal | Director | M-Exempt | D | Restricted Stock Units | 96,150 | 0.00 | — | 0 | — | ↗ |
| 2023-03-01 | Monahan Joseph | Officer | M-Exempt | A | Common Stock | 10,925 | 0.00 | — | 166,061 | — | ↗ |
| 2023-03-01 | Balthaser Kevin | Officer | M-Exempt | D | Restricted Stock Units | 2,375 | 0.00 | — | 7,125 | — | ↗ |
| 2023-02-15 | Monahan Joseph | Officer | S-Sale | D | Common Stock | 5,000 | 13.06 | 65.3K | 91,386 | — | ↗ |
| 2023-02-08 | Loerop James | Officer | S-Sale | D | Common Stock | 4,267 | 13.89 | 59.3K | 6,983 | — | ↗ |
| 2023-02-02 | Walker Neal | Director | S-Sale | D | Common Stock | 200 | 17.54 | 3.5K | 1,175,763 | — | ↗ |
| 2023-02-01 | Walker Neal | Director | S-Sale | D | Common Stock | 25,000 | 16.75 | 418.7K | 1,180,763 | — | ↗ |
| 2023-02-01 | Monahan Joseph | Officer | A-Award | A | Restricted Stock Units | 30,000 | 0.00 | — | 30,000 | — | ↗ |
| 2023-02-01 | Manion Douglas J. | Director / Officer | A-Award | A | Restricted Stock Units | 108,000 | 0.00 | — | 108,000 | — | ↗ |
| 2023-02-01 | Loerop James | Officer | M-Exempt | D | Restricted Stock Units | 11,250 | 0.00 | — | 33,750 | — | ↗ |
| 2023-02-01 | Cawkwell Gail | Officer | A-Award | A | Restricted Stock Units | 30,000 | 0.00 | — | 30,000 | — | ↗ |
| 2023-02-01 | Balthaser Kevin | Officer | A-Award | A | Restricted Stock Units | 30,000 | 0.00 | — | 30,000 | — | ↗ |
| 2023-01-04 | Walker Neal | Director | S-Sale | D | Common Stock | 15,000 | 14.89 | 223.3K | 1,205,763 | — | ↗ |
| 2023-01-03 | Walker Neal | Director | S-Sale | D | Common Stock | 1,618 | 16.16 | 26.1K | 1,220,763 | — | ↗ |
| 2023-01-01 | Balthaser Kevin | Officer | — | D | Restricted Stock Units | 9,500 | 0.00 | — | — | — | ↗ |
| 2022-12-15 | Monahan Joseph | Officer | S-Sale | D | Common Stock | 5,000 | 15.88 | 79.4K | 96,386 | — | ↗ |
| 2022-11-14 | SCHIFF ANDREW N | Director | S-Sale | D | Common Stock | 1,371 | 17.08 | 23.4K | 434,455 | — | ↗ |
| 2022-11-11 | SCHIFF ANDREW N | Director | S-Sale | D | Common Stock | 41,160 | 17.06 | 702.2K | 435,826 | — | ↗ |
| 2022-11-10 | SCHIFF ANDREW N | Director | S-Sale | D | Common Stock | 11,395 | 17.02 | 194.0K | 476,986 | — | ↗ |
| 2022-11-08 | Powell Andrew Kenneth William | Director | G-Gift | D | Common Stock | 4,000 | 0.00 | — | 9,856 | — | ↗ |
| 2022-10-26 | SCHIFF ANDREW N | Director | S-Sale | D | Common Stock | 14,540 | 17.01 | 247.3K | 488,381 | — | ↗ |
| 2022-10-25 | SCHIFF ANDREW N | Director | S-Sale | D | Common Stock | 12,018 | 17.02 | 204.5K | 502,921 | — | ↗ |
| 2022-10-24 | SCHIFF ANDREW N | Director | S-Sale | D | Common Stock | 14,616 | 17.01 | 248.6K | 514,939 | — | ↗ |
| 2022-10-18 | SCHIFF ANDREW N | Director | S-Sale | D | Common Stock | 32,093 | 16.89 | 542.0K | 529,555 | — | ↗ |
| 2022-10-17 | SCHIFF ANDREW N | Director | S-Sale | D | Common Stock | 19,944 | 16.05 | 320.1K | 561,648 | — | ↗ |
| 2022-10-17 | Monahan Joseph | Officer | S-Sale | D | Common Stock | 5,000 | 15.98 | 79.9K | 101,386 | — | ↗ |
| 2022-10-07 | SCHIFF ANDREW N | Director | S-Sale | D | Common Stock | 7,324 | 16.16 | 118.3K | 581,592 | — | ↗ |
| 2022-10-06 | SCHIFF ANDREW N | Director | S-Sale | D | Common Stock | 37,839 | 16.54 | 625.7K | 588,916 | — | ↗ |
| 2022-10-04 | SCHIFF ANDREW N | Director | S-Sale | D | Common Stock | 7,700 | 16.01 | 123.3K | 626,755 | — | ↗ |
| 2022-08-01 | Manion Douglas J. | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 217,800 | 0.00 | — | 217,800 | — | ↗ |
| 2022-07-01 | Cawkwell Gail | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 210,000 | 13.83 | 2.90M | 210,000 | — | ↗ |
| 2022-06-27 | Cawkwell Gail | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-06-17 | SCHIFF ANDREW N | Director | S-Sale | D | Common Stock | 19,565 | 15.14 | 296.3K | 0 | — | ↗ |
| 2022-06-03 | SCHIFF ANDREW N | Director | M-Exempt | A | Common Stock | 3,356 | 0.00 | — | 19,565 | — | ↗ |
| 2022-06-03 | Reasons Bryan M. | Director | M-Exempt | A | Common Stock | 3,356 | 0.00 | — | 19,565 | — | ↗ |
| 2022-06-03 | Powell Andrew Kenneth William | Director | M-Exempt | A | Common Stock | 3,356 | 0.00 | — | 13,856 | — | ↗ |
| 2022-06-03 | Molineaux Christopher P. | Director | M-Exempt | D | Restricted Stock Units | 3,356 | 0.00 | — | 0 | — | ↗ |
| 2022-06-03 | Mehra Anand | Director | M-Exempt | A | Common Stock | 3,356 | 0.00 | — | 34,197 | — | ↗ |
| 2022-06-03 | MILANO VINCENT | Director | M-Exempt | D | Restricted Stock Units | 3,356 | 0.00 | — | 0 | — | ↗ |
| 2022-06-03 | GOWEN MAXINE | Director | M-Exempt | A | Common Stock | 3,356 | 0.00 | — | 7,794 | — | ↗ |
| 2022-06-02 | SCHIFF ANDREW N | Director | M-Exempt | D | Restricted Stock Units | 3,356 | 0.00 | — | 0 | — | ↗ |
| 2022-06-02 | Reasons Bryan M. | Director | A-Award | A | Stock Option (Right to Buy) | 15,750 | 0.00 | — | 15,750 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-10.6K
Shares Outstanding
120.60M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Neal Walker Chief Executive Officer | 615.0K | — | 828.4K | 1.58M | 350.6K | — | 3.38M | 71.40% | ↗ |
| 2 | 2025 | Kevin Balthaser Chief Financial Officer | 446.0K | — | 310.6K | 548.4K | 171.7K | 14.0K | 1.49M | 57.63% | ↗ |
| 3 | 2025 | James Loerop | 416.0K | — | 336.8K | 520.1K | 160.2K | 14.0K | 1.45M | 59.22% | ↗ |
| 4 | 2024 | Hugh Davis President and Chief Operating Officer | 62.5K | — | 423.7K | 1.08M | 30.6K | 1.7K | 1.60M | 94.06% | ↗ |
| 5 | 2024 | Neal Walker Chief Executive Officer | 477.4K | — | 170.4K | 421.6K | 372.4K | 3.3K | 1.45M | 40.96% | ↗ |
| 6 | 2024 | Neal Walker Interim Chief Executive Officer | 477.4K | — | 170.4K | 421.6K | 372.4K | 3.3K | 1.45M | 40.96% | ↗ |
| 7 | 2024 | Kevin Balthaser Chief Financial Officer | 444.0K | — | 247.8K | 179.0K | 217.6K | 13.8K | 1.10M | 38.72% | ↗ |
| 8 | 2024 | Kevin Balthaser Chief Financial Officer | 444.0K | — | 247.8K | 179.0K | 217.6K | 13.8K | 1.10M | 38.72% | ↗ |
| 9 | 2024 | Douglas Manion Former Chief Executive Officer and President | 27.1K | — | — | — | — | 829.0K | 856.1K | 0.00% | ↗ |
| 10 | 2023 | Douglas Manion Former President and Chief Executive Officer | 600.0K | — | 1.83M | 4.51M | 198.0K | 13.2K | 7.16M | 88.67% | ↗ |
| 11 | 2023 | Douglas Manion Former Chief Executive Officer and President | 600.0K | — | 1.83M | 4.51M | 198.0K | 13.2K | 7.16M | 88.67% | ↗ |
| 12 | 2023 | Gail Cawkwell Former Chief Medical Officer | 490.0K | — | 509.1K | 1.25M | 137.2K | 13.2K | 2.40M | 73.35% | ↗ |
| 13 | 2023 | Kevin Balthaser Chief Financial Officer | 444.0K | — | 509.1K | 1.25M | 124.3K | 13.2K | 2.34M | 75.20% | ↗ |
| 14 | 2023 | James Loerop Chief Business Officer | 435.0K | — | 509.1K | 1.25M | 121.8K | 13.2K | 2.33M | 75.57% | ↗ |
| 15 | 2023 | Joseph Monahan Chief Scientific Officer | 374.4K | — | 509.1K | 1.25M | 104.8K | 13.2K | 2.26M | 78.17% | ↗ |
| 16 | 2022 | Neal Walker Former Chief Executive Officer | 589.7K | — | 1.43M | 3.45M | 353.8K | 12.2K | 5.84M | 83.63% | ↗ |
| 17 | 2022 | Gail Cawkwell Former Chief Medical Officer | 247.3K | 25.0K | 896.4K | 2.03M | 98.9K | 800.00 | 3.30M | 88.72% | ↗ |
| 18 | 2022 | Gail Cawkwell Chief Medical Officer | 247.3K | 25.0K | 896.4K | 2.03M | 98.9K | — | 3.30M | 88.75% | ↗ |
| 19 | 2022 | Douglas Manion Former President and Chief Executive Officer | 204.2K | — | 848.5K | 2.07M | 82.2K | — | 3.20M | 91.06% | ↗ |
| 20 | 2022 | Douglas Manion President and Chief Operating Officer | 204.2K | — | 848.5K | 2.07M | 82.2K | — | 3.20M | 91.06% | ↗ |
| 21 | 2022 | Frank Ruffo Former Chief Financial Officer | 417.8K | — | 705.6K | 1.87M | 167.1K | 12.2K | 3.17M | 81.19% | ↗ |
| 22 | 2022 | Joseph Monahan Chief Scientific Officer | 420.0K | — | 652.9K | 1.57M | 168.0K | 12.0K | 2.82M | 78.75% | ↗ |
| 23 | 2021 | Neal Walker President and Chief Executive Officer | 566.5K | — | 1.76M | 4.13M | 387.5K | 11.6K | 6.85M | 85.91% | ↗ |
| 24 | 2021 | Neal Walker Former Chief Executive Officer | 566.5K | — | 1.76M | 4.13M | 387.5K | 11.6K | 6.85M | 85.91% | ↗ |
| 25 | 2021 | Joseph Monahan Chief Scientific Officer | 350.0K | — | 4.81M | — | 154.7K | 10.6K | 5.33M | 90.33% | ↗ |
| 26 | 2021 | Kamil Ali-Jackson Former Chief Legal Officer | 391.4K | — | 683.3K | 1.61M | — | 2.01M | 4.69M | 48.86% | ↗ |
| 27 | 2021 | Frank Ruffo Former Chief Financial Officer | 401.7K | — | 798.8K | 1.87M | 177.6K | 11.6K | 3.26M | 81.89% | ↗ |
| 28 | 2021 | Frank Ruffo Chief Financial Officer | 401.7K | — | 798.8K | 1.87M | 177.6K | 11.6K | 3.26M | 81.89% | ↗ |
| 29 | 2021 | David Gordon Former Chief Medical Officer | 424.5K | — | 683.3K | 1.61M | — | 206.7K | 2.92M | 78.39% | ↗ |
| 30 | 2020 | Neal Walker Former Chief Executive Officer | 423.8K | — | 535.8K | 231.8K | 407.9K | 11.4K | 1.61M | 47.66% | ↗ |
| 31 | 2020 | Neal Walker President and Chief Executive Officer | 423.8K | — | 535.8K | 231.8K | 407.9K | 11.4K | 1.61M | 47.66% | ↗ |
| 32 | 2020 | Frank Ruffo Former Chief Financial Officer | 390.0K | — | 125.5K | 105.4K | 179.4K | 11.4K | 811.6K | 28.44% | ↗ |
| 33 | 2020 | Frank Ruffo Chief Financial Officer | 390.0K | — | 125.5K | 105.4K | 179.4K | 11.4K | 811.6K | 28.44% | ↗ |
| 34 | 2020 | Kamil Ali-Jackson Chief Legal Officer | 380.0K | — | 117.1K | 84.3K | 174.8K | 11.9K | 768.0K | 26.22% | ↗ |
| 35 | 2020 | Kamil Ali-Jackson Former Chief Legal Officer | 380.0K | — | 117.1K | 84.3K | 174.8K | 11.4K | 767.6K | 26.24% | ↗ |
| 36 | 2020 | David Gordon Former Chief Medical Officer | 412.1K | — | 41.8K | 105.4K | 189.6K | 11.4K | 760.2K | 19.36% | ↗ |
| 37 | 2019 | Neal Walker President and Chief Executive Officer | 499.9K | — | 2.43M | — | 203.9K | 11.2K | 3.15M | 77.30% | ↗ |
| 38 | 2019 | David Gordon, MB ChB Chief Medical Officer | 406.0K | — | 843.6K | — | 113.7K | 9.4K | 1.37M | 61.46% | ↗ |
| 39 | 2019 | David Gordon Former Chief Medical Officer | 406.0K | — | 843.6K | — | 113.7K | 8.9K | 1.37M | 61.48% | ↗ |
| 40 | 2019 | Frank Ruffo Chief Financial Officer | 390.0K | — | 652.0K | — | 109.2K | 11.2K | 1.16M | 56.09% | ↗ |
| 41 | 2018 | Neal Walker President and Chief Executive Officer | 550.0K | — | 954.3K | 2.63M | 221.1K | 11.7K | 4.36M | 82.06% | ↗ |
| 42 | 2018 | David Gordon, MB ChB Chief Medical Officer | 244.4K | — | 468.7K | 1.33M | 67.9K | 358.00 | 2.12M | 85.22% | ↗ |
| 43 | 2018 | Stuart Shanler, M.D. Chief Scientific Officer | 400.0K | — | 342.4K | 938.0K | 116.4K | 11.7K | 1.81M | 70.80% | ↗ |
| 44 | 2017 | Neal Walker President and Chief Executive Officer | 510.0K | — | — | — | 288.2K | 11.4K | 809.6K | 0.00% | ↗ |
| 45 | 2017 | Christopher Powala Chief Regulatory and Development Officer | 385.0K | — | — | — | 139.8K | 11.4K | 536.2K | 0.00% | ↗ |
| 46 | 2017 | Stuart Shanler, M.D. Chief Scientific Officer | 380.0K | — | — | — | 142.6K | 11.4K | 534.1K | 0.00% | ↗ |
| 47 | 2016 | Neal Walker President and Chief Executive Officer | 420.0K | — | 701.8K | 3.26M | 273.0K | 11.1K | 4.67M | 84.91% | ↗ |
| 48 | 2016 | Kamil Ali-Jackson Chief Legal Officer | 320.0K | — | 401.0K | 1.86M | 128.8K | 11.7K | 2.73M | 83.10% | ↗ |
| 49 | 2016 | Christopher Powala Chief Regulatory and Development Officer | 345.0K | — | 300.8K | 1.40M | 120.8K | 11.7K | 2.18M | 78.06% | ↗ |
| 50 | 2016 | Christopher Powala Chief Operating Officer | 345.0K | — | 300.8K | 1.40M | 120.8K | 11.7K | 2.18M | 78.06% | ↗ |
| 51 | 2015 | Neal Walker President and Chief Executive Officer | 344.9K | — | 335.6K | 4.71M | 138.0K | 11.1K | 5.54M | 91.08% | ↗ |
| 52 | 2015 | Christopher Powala Chief Operating Officer | 305.3K | — | 186.4K | 1.84M | 91.6K | 11.9K | 2.43M | 83.20% | ↗ |
| 53 | 2015 | Stuart Shanler Chief Scientific Officer | 287.5K | — | 166.3K | 1.71M | 86.3K | 45.3K | 2.30M | 81.75% | ↗ |
| 54 | 2014 | Neal Walker President and Chief Executive Officer | 339.9K | — | — | 241.4K | 102.0K | 11.0K | 694.3K | 34.77% | ↗ |
| 55 | 2014 | Stuart Shanler Chief Scientific Officer | 283.3K | — | — | 77.6K | 85.0K | 45.2K | 491.0K | 15.80% | ↗ |
| 56 | 2014 | Christopher Powala Chief Operating Officer | 300.8K | — | — | 79.9K | 90.2K | 11.7K | 482.6K | 16.55% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Neal S. Walker | Co-Founder, Chief Executive Officer & Chairman | 965.6K | — |
| Kevin Balthaser | Chief Financial Officer | 631.7K | male |
| James Loerop | Chief Business Officer | 590.2K | male |
| Hugh Davis | President, Chief Operating Officer & Director | 555.5K | — |
| Roland Kolbeck | Chief Scientific Officer | 492.4K | — |
| Jesse W. Hall | Chief Medical Officer | 371.2K | — |
| Steve Tucker | Executive Vice President of Project Leadership | — | male |
| Ajay Aggarwal | Senior Vice President of Clinical Development | — | male |
| William C. Roberts | Senior Vice President of Corporate Communications & Investor Relations | — | male |
| Jon Jacobsen | Senior Vice President of Chemistry | — | — |
| Matthew Rothman | General Counsel & Corporate Secretary | — | male |
| Meghan Dunsmore | Senior Vice President of Finance | — | female |
ESG Rating
ESG Score History MEDICAL - DIAGNOSTICS & RESEARCH
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ACRS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
